Reports
Reports
Sale
The market growth is expected to be led by North America due to factors such as an increased number of cases related to burn injuries and accidents requiring advanced wound care for better healing. According to the data released by the World Health Organization, despite the preventable nature, burn injuries claim nearly 180,000 lives globally. The majority lies in low- and middle-income countries.
The rising accidental injuries occurring due to road accidents and other circumstances are also contributing to the global advanced wound care market share. Data released by the World Health Organization shows that road traffic crashes claim nearly 1.19 million lives every year. These accidents are also responsible for most of the deaths among people aged between 5-29 years. 92% of global road fatalities occur in low- and middle-income countries, despite these countries having only 60% of the world's vehicles.
The high incidence of road accidents is a major indication for the application of advanced wound care. Advanced wound care has better solutions for injuries taking place due to such incidents which directly contributes to the high demand.
Advanced Wound Care Market Size
Advanced Wound Care Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Advanced Wound Care Market Overview
3.1 Global Advanced Wound Care Market Historical Value (2017-2023)
3.2 Global Advanced Wound Care Market Forecast Value (2024-2032)
4 Global Advanced Wound Care Market Landscape
4.1 Global Advanced Wound Care Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Advanced Wound Care Product Landscape
4.2.1 Analysis by Product Type
5 Global Advanced Wound Care Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Advanced Wound Care Market Segmentation
6.1 Global Advanced Wound Care Market by Product Type
6.1.1 Market Overview
6.1.2 Wound Dressing
6.1.2.1 Foam Dressing
6.1.2.2 Hydrocolloid Dressing
6.1.2.3 Film Dressing
6.1.2.4 Alginate Dressing
6.1.2.5 Hydrogel Dressing
6.1.2.6 Collagen Dressing
6.1.2.7 Other Advanced Dressing
6.1.3 Active Wound Care
6.1.3.1 Biomaterials
6.1.3.2 Skin-substitute
6.1.3.3 Others
6.1.4 Wound Care Devices
6.1.4.1 Negative Pressure Wound Therapy (NPWT)
6.1.4.2 Oxygen And Hyperbaric Oxygen Equipment
6.1.4.3 Electric Stimulation Devices
6.1.4.4 Pressure Relief Devices
6.1.4.5 Others
6.2 Global Advanced Wound Care Market by Wound Type
6.2.1 Market Overview
6.2.2 Chronic Wounds
6.2.2.1 Pressure Ulcers
6.2.2.2 Diabetic Foot Ulcers
6.2.2.3 Arterial and Venous Ulcers
6.2.2.4 Others
6.2.3 Acute Wounds
6.2.3.1 Burns and Trauma
6.2.3.2 Surgical Wounds
6.3 Global Advanced Wound Care Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centres
6.3.5 Homecare Settings
6.3.6 Others
6.4 Global Advanced Wound Care Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Advanced Wound Care Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Advanced Wound Care Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Advanced Wound Care Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Advanced Wound Care Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Advanced Wound Care Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding & Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 3M
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Smith & Nephew plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Integra LifeSciences Holdings Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Mölnlycke Health Care AB
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ConvaTec Group plc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Coloplast A/S
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medline Industries, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Advanced Medical Solutions Group plc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hollister Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 B. Braun Melsungen AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 DeRoyal Industries, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 PAUL HARTMANN AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Zimmer Biomet
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Cardinal Health
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 DermaRite Industries, LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Shield Line
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Advanced Wound Care Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 10.05 billion in 2023, driven by increasing incidence of chronic wounds and injuries requiring advanced wound care.
The market is anticipated to grow at a CAGR of 6.9% during the forecast period of 2024-2032, likely to reach a market value of USD 18.32 billion by 2032.
The key drivers aiding the market growth include the rising prevalence of diabetes, rising research and development in the market, increasing investments, rising disposable incomes, and the rapidly advancing healthcare sector.
Key players like Samsung exploring different fields to develop innovative devices to provide options to consumers in the form of wearables with considerable accuracy to keep track of their health is a major trend influencing the market growth.
Various types of products include wound dressing active wound care, and wound care devices.
Chronic and acute wounds are treated in advanced wound care.
End users in the market are hospitals, clinics, ambulatory surgical centres, homecare settings, and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are 3M, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Mölnlycke Health Care AB, ConvaTec Group plc., Coloplast A/S, Medline Industries, Inc, Advanced Medical Solutions Group plc, Hollister Incorporated, B. Braun Melsungen AG, DeRoyal Industries, Inc., PAUL HARTMANN AG, Zimmer Biomet, Cardinal Health, DermaRite Industries, LLC, and Shield Line.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.